NABCOP Conference Presentations 2021 – 2022

ABS Annual Conference, 2021:

1. Post-mastectomy radiotherapy in older women with early invasive breast cancer – data from the National Audit of Breast Cancer in Older Patients (NABCOP). [Oral Presentation]
2. Developing a patient guide to encourage questions and support decision-making around breast cancer treatment for older women – experience of the National Audit of Breast Cancer in Older Patients. [Poster Presentation]
3. Validaton of endocrine therapy prescriptions with primary care prescriptions data for women newly diagnosed with invasive breast cancer: application to the NABCOP cohort. [Poster Presentation]

6th Symposium of Primary Breast Cancer in Older Women, 2022:

1. Adjuvant chemotherapy and trastuzumab for human epidermal growth receptor 2 positive early invasive breast cancer among older women in England: a population-based cohort study using routine data. [Oral Presentation]
2. Developing a patient guide to encourage questions and support decision-making around breast cancer treatment for older women – experience of the National Audit of Breast Cancer in Older Patients. [Poster Presentation]
3. Linking NABCOP findings to the patient pathway to encourage questions, support decision-making and improve breast cancer treatment for older women. [Poster Presentation]

ABS Annual Conference, 2022:

1. Does the association between survival and receipt of post-mastectomy radiotherapy vary by age at diagnosis among women with early invasive breast cancer? [Oral Presentation]
2. The association between guideline adherence, age and overall survival among women with non-metastatic breast cancer: a systematic review. [Poster Presentation]
3. Change in the use of fractionation in radiotherapy used for early breast cancer at the start of the COVID-19 pandemic: a population-based cohort study of older women in England and Wales. [Poster Presentation]
4. Does travel burden influence the use of radiotherapy after surgery for early invasive breast cancer in England? [Poster Presentation]